Immunic AG | WebDisclosure

Switch to English

8296	Sociétés
114902	Mots-clés
55328	Articles
62458	Communiqués

Accueil
Sociétés
Immunic AG

COMMUNIQUÉ DE PRESSE

publié le 04/04/2024 à 12:30, il y a 7 mois 17 jours

Immunic to Host MS R&D Day and Participate in Investor Conferences in April
Immunic, Inc. to host Multiple Sclerosis (MS) Research and Development (R&D) Day and participate in investor conferences in April, showcasing latest developments and clinical data

Investor Conferences Immunic Inc. Clinical Pipeline Multiple Sclerosis R&D Day
BRÈVE

publiée le 20/03/2024 à 11:35, il y a 8 mois 1 jour

Immunic obtient l'autorisation d'un brevet américain pour une nouvelle formulation de calcium Vidofludimus

Propriété Intellectuelle Vidofludimus Calcium Maladies Auto-immunes Immunitaire Brevet Polymère
BRÈVE

publiée le 20/03/2024 à 11:35, il y a 8 mois 1 jour

Immunic Secures U.S. Patent Allowance for Novel Vidofludimus Calcium Formulation

Intellectual Property Immunic Vidofludimus Calcium Autoimmune Diseases Polymer Patent
COMMUNIQUÉ DE PRESSE

publié le 20/03/2024 à 11:30, il y a 8 mois 1 jour

Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States
Immunic receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States, enhancing intellectual property protection

Patent Intellectual Property Immunic Vidofludimus Calcium Notice Of Allowance

Les Echos

Publié le 21/11/2024 à 06:58, il y a 6 heures 31 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 6 heures 31 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 6 heures 31 minutes

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 17 heures 22 minutes

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 18 heures 9 minutes

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 21/11/2024 à 13:00, il y a 29 minutes

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Publié le 21/11/2024 à 13:00, il y a 29 minutes

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Publié le 21/11/2024 à 13:00, il y a 29 minutes

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Publié le 21/11/2024 à 13:00, il y a 29 minutes

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Publié le 21/11/2024 à 13:00, il y a 29 minutes

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

Voir tout ACCESSWIRE

EQS Group

Publié le 21/11/2024 à 13:15, il y a 14 minutes

NOTICE OF ANNUAL GENERAL MEETING
Publié le 21/11/2024 à 12:35, il y a 54 minutes

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Publié le 21/11/2024 à 12:15, il y a 1 heure 14 minutes

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Publié le 21/11/2024 à 12:06, il y a 1 heure 22 minutes

IVU AG publishes Quarterly Report Q3-2024
Publié le 21/11/2024 à 12:00, il y a 1 heure 29 minutes

Holding(s) in Company